MTOR and gastric cancer: Zhang et al. demonstrated that BEZ235, a dual PI3K/mTOR inhibitor, enhances the effects of nab-paclitaxel in GC through regulating the PI3K/mTOR pathway and inhibiting cell proliferation [23].